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Abstract
Background: In clinical and research practice linked to prostate cancer treatment, frequent
monitoring of patient health-related quality of life (HRQOL) is essential. Practical and analytic
limitations of paper questionnaire data capture may be overcome with the use of self-administered
personal digital assistant (PDA) data collection. The objective of this study was to assess the
reliability, validity, and feasibility of using PDA in place of paper versions of the International
Prostate Symptom Score (IPSS), the Patient Oriented Prostate Cancer Utility Survey (PORPUS),
and the International Index of Erectile Function-5 (IIEF-5) in a prostate cancer clinic setting.
Methods: 152 participants were randomly assigned to one of three conditions: 1) paper followed
by PDA survey; 2) PDA followed by paper survey; or 3) PDA followed by PDA survey. Evaluation
included an assessment of data quality (internal consistency, test-retest reliability, response
correlation, completeness of data), and feasibility (participation rates, time to completion,
preference and difficultly/ease of using PDA).
Results:  Internal consistency was similar for both PDA and paper applications. Test-retest
reliability was confirmed for PDA repeated administration. Data from paper and PDA
questionnaires were strongly correlated. Lower missed item rates were found in PDA
administration. 82.8% of participants preferred using the PDA or had no preference. Mean
difficulty/ease ratings indicated that participants found the PDA easy to use. Age did not significantly
correlate with preference or difficulty.
Conclusion: The results confirm the adaptability of the IPSS, IIEF-5, and the PORPUS to PDA
administration. Similarly, the findings of this study support the feasibility of using PDA technology
for HRQOL serial data capture in the prostate cancer patient population.
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Background
The long term survival rates and treatment side-effect pro-
files of most prostate cancer patients combine to empha-
size the importance of serial monitoring of health-related
quality of life (HRQOL) in advancing clinical care and
treatment outcome research. With the advent of prostate
specific antigen (PSA) testing, prostate cancer detection
rates continue to increase resulting in more and younger
men having to cope with the impact of treatment on
HRQOL. Specific HRQOL areas of concern for this popu-
lation of men include sexual, urinary, and bowel dysfunc-
tion [1,2]. These side-effects are also known to change
over time and can have considerable impact on the
patient's emotional, functional, and social well-being [2-
4].
Frequent and systematic collection of HRQOL informa-
tion in the prostate cancer patient population is therefore
necessary for informed treatment decision-making, thor-
ough patient care, and comprehensive evaluation of treat-
ment outcome. In collecting this ongoing data, traditional
paper questionnaires can be problematic within the clinic
setting. For example, if clinical decision-making necessi-
tates input from patient questionnaire data, the paper for-
mat can require too much processing time to be helpful
under the usual time constraints of the clinical consulta-
tion [5]. Furthermore, whether the questionnaire data are
electronically scanned or manually entered into a clinic
database for analysis, the integrity of the data is vulnerable
to data entry errors [6]. These limitations to the traditional
paper questionnaire data capture method may be over-
come with the use of an electronic data collection system.
Electronic data capture with desktop computers (includ-
ing touch-screen applications) [7,8], tablets [9], or hand-
held personal digital assistants (PDA) [6,10,11] has been
shown to improve data quality and allow for immediate
and effective data manipulation. Electronic data collec-
tion improves data quality by providing software safe-
guards against entry omission and inconsistent response
sets, and by completely eliminating data entry errors at the
researcher's level. Moreover, because the data are captured
electronically, data manipulation and analysis can be
achieved faster than is possible with a paper data capture
format. Indeed, results can be immediately scored, dis-
played and printed, allowing the clinician to review and
interpret a patient profile in the company of the patient
and discuss possible treatment decisions [6,10,11].
Although there may be a relatively significant start-up cost
associated with electronic data collection, costs associated
with questionnaires (paper and reproduction), data entry,
coding, and cleaning are either eliminated or substantially
reduced [6]. Additionally, advances in technology con-
tinue to result in reduced costs associated with electronic
data collection computer devices and software [10,12].
Handheld PDA devices may be particularly economical
and effective for electronic data collection in high traffic
clinical healthcare settings [13-16]. PDA technology
meets or exceeds the hardware requirements necessary for
data collection in most clinical healthcare research. Given
the low individual unit cost, multiple PDA units can be
deployed at a fraction of the cost of a single desktop, lap-
top or tablet. The portability of the PDA offers greater flex-
ibility within a clinic setting, less demand for clinic space
(e.g. workstation) and, due to PDA energy efficiency,
reduced dependence on battery power compared to lap-
tops or tablets.
Moreover, for security purposes, PDA software allows for
only a single patient's data to be collected at any one time.
The data collected are protected through the use of multi-
ple levels of encryption and a password access system.
Once the PDA has been synchronized with the personal
computer (PC), the patient self-reported data are purged
from the unit. These features ensure that only the current
user's data are stored on the PDA and that the data are
only accessible to appropriate clinic staff. All other medi-
cal data are stored in the Prostate Centre main database
and are not directly accessible on either the PC or PDA.
The Prostate Centre database is safeguarded through
industry standard security and operational protections.
Therefore, if a PDA device is lost or stolen, sensitive infor-
mation will not be accessible.
These advantages notwithstanding, there are some draw-
backs to PDA data collection. A potential problem with
electronic data collection devices, including the PDA, is
that lack of computer literacy may cause some patients to
prefer paper forms to computerized versions [17]. The
majority of studies, however, document patient accept-
ance of and preference for using PDAs over paper forms
[12,14,17,18]. Patients have also reported difficulty in
seeing the questions due to the relatively small display
screens in PDA [7,19]. Increasing text font size and
restricting the amount of text per screen can overcome this
limitation. As well, some patients may be unfamiliar with
using PDA devices and may require guidance/training
from clinic staff.
Before PDA data collection techniques can be justifiably
used for clinical or research purposes in healthcare clinics,
this mode of data collection needs to be adequately vali-
dated for use with specific measures and patient popula-
tions. The aim of this project is to compare self-
administered HRQOL measures in a PDA version with a
paper version. Evaluation includes an assessment of data
quality (internal consistency, test-retest reliability,Health and Quality of Life Outcomes 2007, 5:38 http://www.hqlo.com/content/5/1/38
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response correlation, completeness of data), and feasibil-
ity (participation rates, time to completion, preference,
and difficultly/ease of using PDA). The unique relevance of
this research is its focus on 1) the responses of prostate can-
cer patients to the PDA data collection system, and 2) the
adaptability of the International Prostate Symptom Score
(IPSS), the Patient Oriented Prostate Cancer Utility Survey
(PORPUS), and the International Index of Erectile Func-
tion-5 (IIEF-5) to the PDA format.
Methods
Participant selection and study design
Prostate cancer patients at the outpatient clinic of the
Prostate Centre, Princess Margaret Hospital, Toronto,
between April 1 and July 15, 2006 were considered for
participation in the study. Eligible patients were identified
by the uro-oncologists and the research team prior to
attending each outpatient clinic. Potential participants
were approached in the clinic upon registering at recep-
tion and the particulars of the study and specific informa-
tion on the requirements of participation were described.
Informed consent was obtained from all eligible patients
agreeing to participate. Where possible, reasons for refus-
ing to participate were recorded along with the patient's
age and treatment stage (pretreatment or time since treat-
ment). Inclusion criteria included prostate cancer patients
(new or follow-up patients) who could read, speak and
write English, and who did not have significant hearing or
visual impairment. All patients meeting these criteria were
invited to participate. This study received approval from
the University Health Network Research Ethics Board.
One hundred and fifty-two (n = 152) participants were
randomly assigned using a random number generator
[20] to one of three HRQOL survey administration condi-
tions: 1) paper survey followed by PDA survey; 2) PDA
survey followed by paper survey; or 3) PDA survey fol-
lowed by PDA survey. Each participant was asked to com-
plete one survey administration at clinic check-in and one
after a 30-minute wait period prior to their clinical consul-
tation with the uro-oncologist. The separation in time
between completing the two survey administrations
allowed for the avoidance of immediate recall respond-
ing, and analysis of test-retest reliability of the PDA
modality (Condition 3). The alternating paper/PDA sur-
vey administrations (Conditions 1, 2) was designed to
allow for control of order effects. All participants were
given a brief (less than 1 minute) tutorial on using the
PDA. Patients were shown how to select a response by tap-
ping the stylus to the PDA, and were instructed on how to
enter their date of birth, hospital ID number, and how to
proceed to the next screen.
Following completion of two survey administrations
(Conditions 1, 2 or 3), participants were given a one-page
questionnaire examining the level of difficulty/ease using
the PDA and survey format preferences. All participants
were asked to rate ease/difficulty by completing a 10-
point visual analogue scale (VAS) ranging from "Very Dif-
ficult" (0) to "Very Easy" (10). Patients participating in
conditions 1 and 2 were then asked to complete a 10-
point VAS examining format preferences, ranging from
paper questionnaire (0) to PDA questionnaire (10). The
cut-off score used to determine ease of use and preference
for PDA was 5.1. All participants were given the opportu-
nity to comment on what they liked/disliked about the
PDA format.
Materials
Health-related quality of life measures
All participants were asked to complete a paper and/or
PDA version of the International Prostate Symptom Score
(IPSS) [21], the Patient Oriented Prostate Cancer Utility
Survey (PORPUS) [22], and the International Index of
Erectile Function-5 (IIEF-5) [23]. The IPSS is an 8-item
measure of patient urinary voiding function commonly
used in prostate cancer research [24-28]. The PORPUS is a
prostate cancer specific measure of HRQOL. The 10-item
psychometrically validated instrument assesses ten qual-
ity of life domains: energy, pain, emotional well-being,
support from family/friends, communication with doc-
tor, erectile function, sexual interest, urinary frequency,
bladder control and bowel symptoms. The IIEF-5 is a
short-form version of the International Index of Erectile
Function [29], and is used in clinical settings to assess
erectile dysfunction. The questions explore maintenance
ability, erection confidence, maintenance frequency, erec-
tion firmness and intercourse satisfaction [23]. All of the
measures are reliable and valid [21,30,31].
In order to adapt the IPSS, IIEF-5, and PORPUS to the
PDA device, the questions were presented one question
per PDA screen. Consequently, in comparison to paper
forms, participants completing the PDA version were able
to see only one question at a time (Figure 1).
Personal Digital Assistant PMH Prostate-HRQOL System
The HRQOL PDA data collection and capture system was
developed by the research team. Software was developed
for the PDA that allowed a single participant to enter
demographics and survey response information.
Responses to survey questions were entered by pressing
the stylus to the box located beside the chosen statement.
Participants had the option of skipping questions by
pressing the "Next" button without providing a response.
Following completion of the questionnaire, participants
who had skipped questions were presented with a screen
containing the following statements: "You did not answer
on or more of the [survey] questions. Please tap 'Next' and
answer the missed questions." The missed questions wereHealth and Quality of Life Outcomes 2007, 5:38 http://www.hqlo.com/content/5/1/38
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then repeated, giving participants the option to complete
each of the unanswered questions or to confirm that they
have chosen to skip the questions (Figure 2).
Upon completion of the survey, the participant returned
the PDA to research staff for data synchronization with a
PC. During the synchronization, demographics informa-
tion was checked against that of known patients stored in
a relational database on the PC. If no demographics
match was found, the participant was asked to correct his
demographics information on the PDA and resynchronize
(survey responses were preserved). Otherwise, survey data
from the PDA was transferred into the database on the PC,
a report was generated for the patient, and the PDA was
cleared of data in preparation for the next user.
PDA software was developed in C++ for the Palm Vx series
of PDAs. All surveys were administered using Palm Vx
PDAs. Synchronization (Palm COM Conduit) and report
generation software was written in Visual Basic [32].
Microsoft Access [33] was used as a relational database to
transfer data to the Statistical Package for the Social Sci-
ences (SPSS) [34].
Paper HRQOL Survey
Paper surveys were marked with identification numbers
and handed to participants by study investigators. Partici-
pants were supplied with a pen and clipboard, and
instructed to complete questionnaires in the clinic waiting
room. Upon completion of the survey, participants
returned the questionnaire package to study investigators.
Survey data were entered by an investigator into SPSS
[34].
Statistical methods
Comparisons of characteristics between non-respondents
and respondents, and amongst the three experimental
conditions were made using chi-square and t-tests. Demo-
graphic characteristics of participants are shown in Table
1.
Data quality
Internal consistency of related questionnaire items within
administration mode (PDA and Paper) was assessed by
Cronbach's alpha. Test-retest reliability within the PDA
capture mode and concurrent validity  examining the
reproducibility between the initial administration and
Side by side comparison: PDA and paper/pencil survey Figure 1
Side by side comparison: PDA and paper/pencil survey.
6 5 4 3 2 1 0 If you were to spend the 
rest of your life with your 
urinary condition just the 
way it is now, how would 
you feel about that?
Terrible Unhappy Mostly 
dissatisfied
Equally 
satisfied & 
dissatisfied
Mostly 
satisfied
Pleased Delighted
5 4 3 2 1 0 7. How many times did you most typically 
get up to urinate from the time you went to 
bed at night until the time you got up in the 
morning?
5 Times 
or more
4 Times 3 Times 2 Times 1 Time None
5 4 3 2 1 0 6. How often have you had to push or strain 
to begin urination?
5 4 3 2 1 0 5. How often have you had a weak urinary 
stream?
5 4 3 2 1 0 4. How often have you found it difficult to 
postpone urination?
5 4 3 2 1 0 3. How often have you found you stopped 
and started again several times when you 
urinated?
5 4 3 2 1 0 2. How often have you had to urinate again 
less than two hours after you finished 
urinating?   
5 4 3 2 1 0 1. How often have you had a sensation of 
not emptying your bladder completely after 
you finish urinating?
Almost 
always
More than 
half the 
time
About half 
the time
Less than 
half the time
Less than 1 
time in 5
Not at all
6 5 4 3 2 1 0 If you were to spend the 
rest of your life with your 
urinary condition just the 
way it is now, how would 
you feel about that?
Terrible Unhappy Mostly 
dissatisfied
Equally 
satisfied & 
dissatisfied
Mostly 
satisfied
Pleased Delighted
5 4 3 2 1 0 7. How many times did you most typically 
get up to urinate from the time you went to 
bed at night until the time you got up in the 
morning?
5 Times 
or more
4 Times 3 Times 2 Times 1 Time None
5 4 3 2 1 0 6. How often have you had to push or strain 
to begin urination?
5 4 3 2 1 0 5. How often have you had a weak urinary 
stream?
5 4 3 2 1 0 4. How often have you found it difficult to 
postpone urination?
5 4 3 2 1 0 3. How often have you found you stopped 
and started again several times when you 
urinated?
5 4 3 2 1 0 2. How often have you had to urinate again 
less than two hours after you finished 
urinating?   
5 4 3 2 1 0 1. How often have you had a sensation of 
not emptying your bladder completely after 
you finish urinating?
Almost 
always
More than 
half the 
time
About half 
the time
Less than 
half the time
Less than 1 
time in 5
Not at allHealth and Quality of Life Outcomes 2007, 5:38 http://www.hqlo.com/content/5/1/38
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repeat administration of the two data capture modes was
assessed by the intraclass correlation coefficients (ICC) of
a 2-way mixed model reliability model. The ICCs were
computed on the total scores for the IPSS, IIEF-5, and for
the 10 separate domains of the PORPUS. To investigate
possible order effects, an independent sample t-test was
used to compare conditions 1 and 2 in terms of variation
in scores in the first and second administration. Com-
pleteness of data was compared between modes of appli-
cation on an individual item basis across the three health
measures.
Feasibility
To assess feasibility of using the PDA versus paper admin-
istration modes of the HRQOL questionnaires, participa-
tion rates, time to completion, and patient preference
were recorded in administration conditions 1 and 2, and
difficulty with using the PDA administration in adminis-
tration conditions 1, 2, and 3. Statistical analysis was per-
formed using SPSS [34].
Results
Sample characteristics
A total of 216 patients were approached to participate in
the study over a 3.5 month period between April 1 and
July 15, 2006. Thirty-one patients (22%) declined to par-
ticipate. The reasons for refusal included: 18 patients
(8%) did not want to complete any questionnaires (paper
or PDA versions), 5 patients (2%) did not have their eye-
glasses, 2 patients (1%) reported time constraints, 1
patient (0.5%) stated that he was uncomfortable with
'electronics', and the remaining 5 patients (2%) did not
provide a reason for non-participation. A further 16
patients failed to complete the entire study protocol and
were excluded from the analysis. Reasons for partial par-
ticipation included time constraints and a refusal to com-
plete the questionnaire for a second time. A chi-square
analysis revealed these partial respondents were equally
represented across experimental conditions. An addi-
tional 17 (8%) participants were excluded from the study
because clinic wait-times were less than 30 minutes and
did not allow for second administration of the question-
naires. Therefore, 152 patients were included in the anal-
ysis, 70% of those initially approached about the study.
No significant differences were observed between partici-
pants and non-participants on age and purpose of clinic
visit (elevated risk, cancer diagnosis, treatment follow-
up).
As a result of random number assignment, 53 participants
completed the paper survey followed by PDA survey
(Condition 1), 53 participants completed the PDA survey
followed by paper survey (Condition 2), and 46 partici-
pants completed the PDA survey followed by another
administration of the PDA survey (Condition 3). Between
group analysis of participant age and purpose of clinic
visit revealed no significant differences (Table 1) amongst
the three conditions.
PDA skipped question confirmation screen Figure 2
PDA skipped question confirmation screen.
Table 1: Comparison of characteristics of respondents by experimental condition
Reason for Clinic Visit
Condition N (% of total) Mean Age (S.D.) Age Range 
(years)
Elevated Risk 
(%)
Diagnosis (%) Treatment 
Follow-up (%)
1) Paper/PDA 53 (35) 68.7 (10.4) 39 to 89 32 (60) 6 (11) 15 (28)
2) PDA/Paper 53 (35) 67.1 (10.2) 45 to 86 24 (45) 5 (9) 24 (45)
3) PDA/PDA 46 (30) 65.9 (10.3) 47 to 87 23 (50) 3 (7) 20 (43)Health and Quality of Life Outcomes 2007, 5:38 http://www.hqlo.com/content/5/1/38
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Data quality
Internal consistency coefficients (Cronbach's alpha)
across the IPSS and IIEF-5 revealed excellent internal con-
sistency for both the PDA and paper applications (Table
2).
ICCs used to measure test-retest reliability in Condition 3
for repeated PDA administration of the IPSS, IIEF-5, and
the PORPUS quality of life domains are shown in Table 3.
The large magnitude correlation coefficients are all highly
significant (p < 0.01).
ICCs reveal that the total scores by patients completing
paper and PDA questionnaires were strongly correlated
(Table 4a and 4b). This provides evidence of concurrent
validity across administration modalities. The correlation
coefficients reported are all highly significant (P < 0.01).
An independent sample t-test was used to compare condi-
tions 1 and 2 in terms of the variation in scores inputted
in the first and second administration. Non-significant t-
scores suggest that there was no order effect. A final aspect
of data quality that was measured included a comparison
of completeness of data collected via the two modes of
administration. Examination of individual item comple-
tion in Condition 1 revealed that when completing the
IPSS, IIEF-5 and PORPUS in the paper format, 10%,
27.7%, and 7.5% of respondents failed to complete at
least one question. In comparison, when completing the
IPSS, IIEF-5, and PORPUS in the PDA format, 0%, 13.6%,
and 7.5% of respondents failed to complete at least one
question. Similarly, the same analysis in Condition 2
revealed that 11.3%, 17.0%, and 5.1% of the items were
missed in the paper administration version of the IPSS,
IIEF-5, and PORPUS, respectively. In contrast only 0%,
6.8%, and 5.7% of the items were missed on the PDA
administration versions of the IPSS, IIEF-5, and PORPUS,
respectively. Finally, the analysis of Condition 3 revealed
exactly the same results for the first and second adminis-
tration of the questionnaire using the PDA. Missed item
rates for the IPSS, IIEF-5, and PORPUS were 0%, 0%, and
8.7% respectively.
Feasibility
A Pearson chi-square was used to assess possible differ-
ences in level of participation (full, partial, decline) across
experimental condition (1, 2, 3) for all 216 patients
approached for participation in this study. No significant
differences were found. As well, in comparing mode of
application, participants were able to complete the survey
significantly faster using the PDA. Mean times for comple-
tion using the paper survey for conditions 1 and 2 were
Table 2: Internal consistency coefficients by measure
Mode of Application IPSS (Cronbach's alpha range) IIEF-5 (Cronbach's alpha range)
Paper .78 to .85 .97 to .98
PDA .85 to .87 .97 to .98
Note: This analysis was not performed on the PORPUS as this scale uses 10 independent questions to measure 10 quality of life domains and is not 
an appropriate scale for internal consistency analysis.
Table 3: Intraclass correlation coefficients of PDA administration of questionnaires
Measure N PDA – 1st Administra-
tion Mean (S.D.)
PDA – 2nd Administra-
tion Mean (S.D.)
ICC (C.I.)
IPSS 46 11.70 (8.96) 9.57 (8.33) 0.960 (0.929–0.978)
IIEF-5 35 14.94 (8.32) 16.06 (8.82) 0.946 (0.896–0.972)
PORPUS
Pain 44 0.40 (0.65) 0.42 (0.78) 0.714 (0.532–0.833)
Energy 46 1.18 (0.97) 1.11 (0.97) 0.976 (0.958–0.987)
Social support 46 0.30 (0.72) 0.11 (0.38) 0.928 (0.874–0.960)
Communication with 
doctor
45 0.17 (0.42) 0.22 (0.42) 0.589 (0.360–0.751)
Emotional well-being 46 0.80 (0.94) 0.59 (0.91) 0.910 (0.844–0.949)
Urinary frequency/urgency 44 1.19 (0.91) 1.15 (0.94) 0.867 (0.768–0.925)
Leaking urine 45 1.00 (1.19) 0.98 (1.27) 0.840 (0.726–0.909)
Sexual function 41 1.72 (1.54) 1.60 (1.62) 0.973 (0.950–0.986)
Sexual interest 42 1.25 (1.47) 1.05 (1.38) 0.878 (0.785–0.933)
Bowel problems 43 0.21 (0.45) 0.20 (0.46) 0.873 (0.777–0.929)
*All correlations are significant at p ≤ 0.01Health and Quality of Life Outcomes 2007, 5:38 http://www.hqlo.com/content/5/1/38
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12.5 minutes, and 10.2 minutes, respectively, compared
to 11.2 minutes and 8.6 minutes respectively using the
PDA format.
Preference for using paper or PDA modes of application
was measured using a 10-point VAS, ranging from paper
preference to PDA preference. Results of the analysis
revealed that 58.6% of patients preferred using the PDA
format, 24.2% had no preference, and 17.2% preferred
the paper format. To determine if age had an impact on
preference, a Pearson correlation coefficient was com-
puted between age and the mode preference scale. The
correlation coefficient was weak (r = 0.16, p = 0.12) and
not statistically significant. In a similar fashion, difficulty
of use of the PDA administration was also measured using
a 10-point VAS. The mean score was 8.6. Again, there was
a weak and non-significant correlation between age and
scores on the visual analogue difficulty scale (r = -0.15, p
= 0.08).
All participants were provided with a brief tutorial on
using the PDA. Following the tutorial, a research assistant
documented the frequency and content of questions
asked by participants while using the PDA. The majority
of patients (76%) were able to complete PDA adminis-
tered questionnaires without requiring further instruc-
tion. Twenty-nine (19%) patients were able to complete
the PDA administered questionnaire by presenting with 1
or 2 follow-up questions or concerns, and the remaining
7 (5%) patients presented 3 or more inquiries. Questions
or concerns included difficulty recording answers on the
PDA as a result of stylus-device insensitivity. Other inquir-
ies included how to skip questions, and how to correct
errors entering hospital ID or date of birth. Four patients
required assistance with the paper questionnaire.
Discussion
Data quality
The results of this study showed that PDA administration
of the IPSS, IIEF-5, and the PORPUS was psychometrically
Table 4a: Concurrent validity across administration modalities – Condition 1 (Paper/PDA)
Measure Paper: Mean (S.D.) PDA: Mean (S.D.) N1 ICC (C.I.)
IPSS 10.9 (6.88) 9.8 (6.62) 52 0.901 (0.834–0.942)
IIEF-5 11.39 (8.25) 12.39 (7.73) 41 0.963 (0.931–0.980)
PORPUS
Pain 0.41 (0.77) 0.43 (0.75) 53 0.92 (0.865–0.953)
Energy 1.5 (0.91) 1.53 (0.89) 53 0.898 (0.830–0.940)
Social support 0.25 (0.69) 0.29 (0.72) 52 1 (1.00–1.00)
Communication with doctor 0.26 (0.52) 0.42 (0.949) 52 0.38 (0.122–0.590)
Emotional well-being 0.73 (0.86) 0.74 (0.74) 53 0.78 (0.647–0.867)
Urinary frequency/urgency 1.1 (0.75) 1.08 (0.76) 52 0.818 (0.702–0.891)
Leaking urine 0.88 (0.8) 1.23 (1.07) 53 0.551 (0.332–0.714)
Sexual function 2.17 (1.49) 2.06 (1.42) 51 0.924 (0.871–0.956)
Sexual interest 1.53 (1.42) 1.67 (1.38) 50 0.934 (0.886–0.961)
Bowel problems 0.4 (0.59) 0.34 (0.52) 53 0.933 (0.886–0.961)
*All correlations are significant at p ≤ 0.01
Table 4b: Concurrent validity across administration modalities – Condition 2 (PDA/Paper)
Measure Paper: Mean (S.D.) PDA: Mean (S.D.) N1 ICC (C.I.)
IPSS 10.88 (7.5) 9.08 (6.41) 53 0.82 (0.707–0.892)
IIEF-5 11.18 (7.5) 12.27 (8.48) 39 0.86 (0.751–0.923)
PORPUS
Pain 0.47 (0.72) 0.46 (0.75) 52 0.696 (0.524–0.814)
Energy 1.46 (0.95) 1.36 (0.96) 53 0.88 (0.800–0.929)
Social support 0.33 (0.86) 0.32 (0.85) 53 0.987 (0.977–0.992)
Communication with 
doctor
0.47 (0.70) 0.36 (0.65) 53 0.922 (0.868–0.954)
Emotional well-being 0.86 (0.97) 0.90 (0.93) 52 0.958 (0.928–0.976)
Urinary frequency/urgency 1.24 (0.97) 0.92 (0.9) 52 0.723 (0.562–0.831)
Leaking urine 1.1 (1.27) 0.87 (1.1) 52 0.869 (0.782–0.923)
Sexual function 2.19 (1.59) 2.17 (1.57) 46 0.992 (0.985–0.995)
Sexual interest 2.02 (1.53) 1.85 (1.63) 47 0.93 (0.878–0.961)
Bowel problems 0.52 (0.78) 0.39 (0.64) 50 0.878 (0.794–0.929)
*All correlations are significant at p ≤ 0.01Health and Quality of Life Outcomes 2007, 5:38 http://www.hqlo.com/content/5/1/38
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comparable to paper administration. Internal consistency
analysis revealed identical coefficients (Cronbach's
alphas) for the IIEF-5 under both modes of application,
and slightly better coefficients for PDA administration of
the IPSS compared to paper survey. The test-retest reliabil-
ity coefficients should be high given that we do not expect
the participant's 'state' to change over the 30-minute test-
ing interval. The generally accepted test-retest reliability
coefficient under these circumstances is above 0.70 [35].
Our analysis found coefficients for the IPSS, IIEF-5, and
nine out of ten domains of the PORPUS exceeded the 0.70
cut-off. "Communication with Doctor" was the one
domain of the PORPUS that produced only a moderate
coefficient of 0.59. This moderate value is similar to the
test-retest coefficient reported for the paper version of the
PORPUS [30] and is therefore not a direct result of the
PDA format. However, in this study, given that the partic-
ipants did not have any direct contact with their physi-
cians in the interval between testing, this moderate
correlation is an unexpected result. The mean score for the
"Communication with Doctor" question increased from
the first to second administration, from 1.7 (S.D. = 0.42)
to 2.2 (S.D. = 0.41) respectively, and represents a self-
reported decrease in communication with doctor. It is
possible that this reported decline in communication is
explained by participant frustration associated with wait-
ing a minimum of 30 minutes to see the physician.
In conditions 1 and 2, we made direct comparisons of
data collected by the paper and PDA formats. Our ICCs
should be high across administration modes given that
our analysis of test-retest reliability suggests scores are sta-
ble over the testing period. Once again, in conditions 1
and 2 we found strong and significant ICCs between
modalities for the IPSS, IIEF-5, and the PORPUS. Excep-
tions were found in our analysis of Condition 1 in which
the PORPUS domains, "Communication with Doctor"
and "Leaking Urine" revealed moderate ICCs of 0.38 and
0.55 respectively. It is not clear why these ICCs are only
moderate and different than those found in our analysis
of Condition 2 (0.92 and 0.87 respectively). Our analysis
of order effects, however, revealed that the difference in
mean scores for the "Communication with Doctor" and
the "Leaking Urine" questions were non-significant (p =
0.44 and p = 0.13, respectively). Unfortunately, closer
examination of participant responses in both conditions
did not lead to a further understanding of this domain-
specific deviation. The overall strong ICCs, however, sug-
gest that researchers and clinicians can be confident that
similar data can be collected using both modes. Our find-
ings are similar to findings in previous literature where
there continues to be very little evidence of mode effects
in data capture [36-38].
Our findings also support previous literature reporting
that PDA administration can enhance completeness of
data collection. No missed items were found in the PDA
mode collection of IPSS data, while 10 to 11% of the
paper surveys contained missed items. The number of
missed items for the PORPUS was low and virtually iden-
tical under both conditions of data collection. For the
IIEF-5 the number of missed items in conditions 1 and 2
was high, although the PDA mode missed-item rate was
less than half that found using paper questionnaires. The
overall elevated number of missed items on the IIEF-5 is
likely due to the sensitive topic of the questionnaire. Our
experience in the serial collection of over 3500 paper IIEF-
5 questionnaires in the Prostate Centre since 2005
(missed-item rate of 17.6%) suggests that the overall
missed-item rate in this study is not unusual. It appears
from the response pattern, patients with little or no erec-
tile functioning complete questions 1 and/or 2 and leave
the remaining 3 questions unanswered. The reason for
our finding of the advantage of the PDA mode in collect-
ing sensitive data is not clear, although this benefit has
been reported in previous literature comparing self-
administered electronic to paper sensitive data capture
[39,40]. It is possible that the single-question per screen in
the PDA administration along with skipped question
reminders (Figure 2) encourages patients to respond to
each question in order to progress to the next screen. As
well, the more "private" or "concealed" nature of the PDA
(i.e. it is difficult for others sitting adjacent to the partici-
pant to see the PDA screen) may support participants in
feeling more comfortable spending time to complete the
entire questionnaire. Overall, this increased data collec-
tion has a direct beneficial impact on the quality of the
data collected.
Feasibility
Our findings strongly support the utility and acceptance
of PDA data capture in a clinically diverse population of
prostate cancer patients. In examining patient preference
for mode of application, 54.6% of patients preferred PDA
questionnaire administration and 24.2% had no prefer-
ence. Thus, 82.8% of the prostate cancer patients attend-
ing our clinic were willing participants to the adaptation
of using PDA technology. Positive comments regarding
PDA administration included: "the PDA is fast and effi-
cient" and "using the PDA will help save paper." Some
study participants (17.2%), stated that they preferred
completing paper questionnaires. The main reason these
patients provided for preferring paper surveys was that
they were "used to them." Another common reason was
that these patients found the stylus awkward to use. Inter-
estingly, this was not because the patients found the stylus
manually difficult to manipulate, but because they
reported being frustrated by encountering difficulties in
recording answers on the PDA as a result of stylus-deviceHealth and Quality of Life Outcomes 2007, 5:38 http://www.hqlo.com/content/5/1/38
Page 9 of 11
(page number not for citation purposes)
insensitivity. It appears that these reasons for non-prefer-
ence can be accommodated through brief training and
adjustment in existing technology. In this regard, we can
also be optimistic about successful use of PDA data collec-
tion within this population given that the majority of par-
ticipants in this study rated the PDA device as very easy to
use. Given the clinical and research benefit of PDA data
capture and that the device is readily acceptable to pros-
tate cancer patients, there appear to be few reasons not to
take advantage of this technology in prostate cancer clin-
ics requiring continuous health status monitoring.
Design Issues
Selection bias
It is important to acknowledge the potential impact of
selection bias in this type of research. Selection bias can
occur in two ways: 1) self-selection of individuals to par-
ticipate in an experimental study; and 2) selection of sam-
ples that may introduce systematic bias to the
generalizability of the findings. Both of these selection
biases represent a challenge to the validity of this study.
First, a specific concern in studying the prostate cancer
population was that older patients may be less familiar or
comfortable with computer technology, and therefore
these patients may decline to participate.
To investigate this potential source of bias, we asked about
the age of patients who declined to participate. Statistical
comparison of the mean age of non-participants to partic-
ipants was non-significant. As well, the age of participants
in the trial indicates representation across a broad age-
range. We were also concerned that patient distress, which
may vary according to a patient's reason for his clinic visit
(e.g. elevated risk, diagnosis and treatment decision-mak-
ing, or treatment follow-up), could influence willingness
to participate in research. Once again, comparisons of
non-participants and participants regarding their reasons
for attending the Prostate Centre revealed no significant
differences. Second, recruitment only included patients
treated by an urologist-co-investigator in a prostate clinic
of a large urban hospital. This sampling method limits the
degree of generalization of our results and may not reflect
outcomes in other settings.
In summary, we acknowledge the common difficulty of
selection bias in this type of research and we attempted to
control for obvious individual patient selection bias,
while recognizing the limits of generalization imposed by
the sample. Comparisons between participants and non-
participants however, suggest that the 152 participants in
this study are representative of patients typically seen in
our specialty prostate cancer treatment centre. Addition-
ally, analysis of level of participation (full, partial, and
decline) did not find a significant difference between con-
ditions, suggesting that we can be confident that selection
bias by condition was controlled for by random group
assignment.
Test-Retest Reliability
Test-retest reliability of the PDA version of the question-
naires was evaluated in Condition 3. In determining the
time interval between questionnaire administrations, two
factors were considered; 1) the longest time interval pos-
sible within the framework of the clinic; and 2) the poten-
tial confounding nature of participant-physician contact.
The majority of patients attending the clinic wait at least
30 minutes prior to seeing the physician; thus, we
attempted the second questionnaire administration 30
minutes after the first administration but prior to any par-
ticipant-physician contact. We would have preferred a
longer interval between testing, however we feel the 30-
minute separation achieves the best possible balance
between the risks of immediate recall versus the potential
influence of extraneous factors during the test-retest time
interval.
Conclusion
The major goals of this study were two-fold: 1) to assess
the reliability and validity of PDA administration of the
International Prostate Symptom Score (IPSS) [21], the
International Index of Erectile Function-5 (IIEF-5) [41],
and the Patient Oriented Prostate Cancer Utility Survey
(PORPUS) [22]; and 2) to determine the feasibility of
serial data capture through patient completed PDA
administered HRQOL questionnaires.
The results of this study confirm the adaptability of the
IPSS, IIEF-5, and the PORPUS to PDA administration.
Analyses of data quality, including internal consistency,
test-retest reliability, and concurrent paper-PDA mode
suggest that the psychometric properties of these ques-
tionnaires are maintained under PDA application. Fur-
thermore, data quality of the PDA mode was superior to
the paper mode due to increased levels of data comple-
tion. The findings of this study also support the feasibility
of using PDA technology for data capture in the prostate
cancer patient population. Assessment of study participa-
tion rates, time to completion, patient preferences, and
difficulty of use revealed that PDA administration met or
exceeded the practicability of regular paper administra-
tion.
Patient acceptability combined with valid and reliable
data capture of the PDA device suggest that PDA technol-
ogy may be efficiently and effectively used by both
researchers and clinicians in the study and treatment of
prostate cancer.Health and Quality of Life Outcomes 2007, 5:38 http://www.hqlo.com/content/5/1/38
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Future directions
A future research direction is the examination of the clin-
ical impact of PDA produced real-time patient-physician
feedback. A significant advantage to the use of PDA
administered surveys is the capability to produce an
immediate print-out of data provided in the survey.
Research reveals that measurement of patient HRQOL can
be used in clinical practice to monitor physical and psy-
chological functioning, inform treatment decision-mak-
ing, and improve care [42]. PDA administration makes
real-time patient-physician feedback practicable even in
high-traffic clinics. One recent study found that oncology
patients receiving immediate feedback of HRQOL infor-
mation report their physicians enquire about daily activity
and emotional problems more often than without com-
puterized results. Furthermore, physicians indicate that
HRQOL information improves communication with
patients and can assist in treatment or disease manage-
ment decisions [42]. Another study indicated cancer
patients experience clinically meaningful improvements
in HRQOL after three sessions of using immediate feed-
back print-outs [43]. Perhaps more importantly, real-time
review of HRQOL information helps physicians identify
patients experiencing significant reductions in quality of
life, thus promoting rapid assessment of patient health
and promoting intervention when necessary [44].
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